A recent comprehensive Danish study has unveiled a critical association between the use of mechanical restraint in psychiatric inpatient settings and an elevated short-term incidence of venous thromboembolism (VTE), commonly known as blood clots. Published in The BMJ, this investigation meticulously evaluated how mechanical restraint—which involves physically restricting a patient’s movement with devices such as waist belts, wrist, or ankle straps—may contribute to a measurable, albeit small, increase in risk for these potentially life-threatening clots. This revelation shines a spotlight on the urgent need to reassess the protocols surrounding restraint use while emphasizing preventive approaches to mitigate VTE risk.
Patients admitted to psychiatric hospitals frequently suffer from severe mental illness conditions that inherently predispose them to an increased baseline risk of thrombotic events. Such predisposition is multifactorial, stemming from coexisting physical health comorbidities and lifestyle factors including smoking, chronic inactivity, and obesity—each known to enhance thrombogenic potential. The immobilization caused by mechanical restraint exacerbates these risks by reducing venous blood flow, thereby fostering conditions conducive to clot formation in the deep veins, typically in the legs, which can subsequently embolize to critical organs such as the lungs.
Mechanical restraints remain a necessary emergency intervention to prevent imminent harm to patients or others when less restrictive strategies fail. Despite their critical role, the pathophysiological consequences of enforced immobility within confined restraints have not been thoroughly quantified in psychiatric populations. This study, therefore, undertook a large-scale observational analysis spanning over two decades (2000–2022), drawing data from all Danish psychiatric hospitals, to rigorously investigate the temporal correlation between restraint application and subsequent VTE events.
The cohort included 24,423 adults aged 18 years and older who were subject to either mechanical restraint or chemical restraint—the latter involving administration of sedative pharmacological agents designed to control aggressive or self-harming behaviors. Among these, a substantial subset of 10,208 individuals experienced mechanical restraint. The median age of mechanically restrained patients was 40 years, with males comprising 68% of that group. Adjustments for confounding variables such as demographics, psychiatric diagnoses, prior medication use, and timing relative to hospital admission enhanced the robustness of these findings by controlling for potential biases inherent in observational designs.
Within a 30-day window post-restraint, the incidence rate of VTE was approximately double in patients subjected to mechanical restraint compared to those given chemical restraint—3.5 events per 1,000 versus 1.7 events per 1,000, respectively. This doubling of risk, while statistically significant, translates to a low absolute risk increase. The authors calculated that for every 548 patients restrained mechanically, there is one excess VTE event attributable to this intervention, assuming a direct causal relationship. This nuanced understanding balances clinical urgency against the imperative to minimize harm from life-saving interventions.
Given the observational nature of the study, causality cannot be definitively established, and residual confounding factors, including variables such as patients’ smoking status and body mass index, not captured in the dataset, may influence outcomes. Nevertheless, the study’s comprehensive population base and systematic inclusion of confounders bolster confidence in the validity of the observed association. This adds valuable evidence to a sparsely researched area, where prior studies have been limited by small sample sizes or incomplete follow-up.
From a mechanistic perspective, the prolonged immobility induced by mechanical restraints likely impairs venous return, triggers endothelial dysfunction, and promotes hypercoagulability. These pathophysiological changes collectively meet Virchow’s triad, the classical framework describing thrombogenesis. The belt or straps may also exert external compression on blood vessels, compounding venous stasis. Understanding these biological underpinnings is crucial in guiding preventive strategies to protect vulnerable psychiatric inpatients.
In light of these findings, the authors emphasize the necessity of rigorous preventive measures targeted at reducing VTE risk in restrained patients. Potential strategies could include pharmacological thromboprophylaxis, vigilant monitoring for early VTE signs, and minimizing the duration and frequency of mechanical restraint use without compromising patient safety. Psychiatry departments are encouraged to refine care protocols, balancing restraint as a safety tool against its inadvertent contribution to vascular morbidity.
The study also triggers a broader dialogue within psychiatric and vascular medicine spheres regarding modifiable risk factors in vulnerable populations. Experts underscore the importance of gathering more detailed clinical data on baseline VTE risk determinants, including smoking habits and body composition, to develop precision medicine approaches. In parallel, novel technological solutions and restraint alternatives that maintain patient dignity and mobility warrant exploration to further decrease thrombotic complications.
A linked editorial accompanying the article underscores restraint as a potentially modifiable risk exposure. It calls for further research incorporating prospective designs and larger, more diverse cohorts to delineate absolute and relative risks accurately. Enhanced understanding will enable clinicians to identify high-risk individuals and tailor restraint practices accordingly. This will forge a path toward safer psychiatric care environments where physical safety and vascular health can be safeguarded simultaneously.
In conclusion, this landmark Danish study illuminates the clinical trade-offs inherent in mechanical restraint use among psychiatric inpatients. While indispensable in certain critical scenarios, the practice is now recognized to carry a small yet significant risk of venous thromboembolism. Healthcare providers, policymakers, and researchers are thus invited to collaborate in developing and implementing comprehensive risk mitigation frameworks, ensuring mechanical restraint is employed judiciously and with enhanced safeguards to protect patient health beyond immediate safety concerns.
Subject of Research: People
Article Title: Venous thromboembolism after mechanical restraint in psychiatric hospitals: population based cohort and self-controlled case series study
News Publication Date: 1-Jul-2026
Web References: http://dx.doi.org/10.1136/bmj-2026-100016
References: The BMJ, Independent Research Fund Denmark
Keywords: Mental health facilities, Thrombosis
